SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 211 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $44 | +18.9% | 25,330 | +119.6% | 0.00% | – |
| Q4 2022 | $37 | -100.0% | 11,533 | -71.5% | 0.00% | -100.0% |
| Q3 2022 | $198,000 | +395.0% | 40,482 | +314.4% | 0.00% | – |
| Q2 2022 | $40,000 | -27.3% | 9,769 | +7.7% | 0.00% | – |
| Q1 2022 | $55,000 | -12.7% | 9,071 | +7.5% | 0.00% | – |
| Q4 2021 | $63,000 | -11.3% | 8,435 | +7.9% | 0.00% | – |
| Q3 2021 | $71,000 | -23.7% | 7,817 | 0.0% | 0.00% | – |
| Q2 2021 | $93,000 | -4.1% | 7,817 | 0.0% | 0.00% | – |
| Q1 2021 | $97,000 | -20.5% | 7,817 | 0.0% | 0.00% | – |
| Q4 2020 | $122,000 | +64.9% | 7,817 | 0.0% | 0.00% | – |
| Q3 2020 | $74,000 | +5.7% | 7,817 | 0.0% | 0.00% | – |
| Q2 2020 | $70,000 | +40.0% | 7,817 | 0.0% | 0.00% | – |
| Q1 2020 | $50,000 | -23.1% | 7,817 | 0.0% | 0.00% | – |
| Q4 2019 | $65,000 | -44.0% | 7,817 | -27.7% | 0.00% | – |
| Q2 2019 | $116,000 | -4.1% | 10,811 | -15.3% | 0.00% | – |
| Q1 2019 | $121,000 | -14.2% | 12,767 | 0.0% | 0.00% | – |
| Q4 2018 | $141,000 | -34.7% | 12,767 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $216,000 | +19.3% | 12,767 | 0.0% | 0.00% | – |
| Q2 2018 | $181,000 | -25.2% | 12,767 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $242,000 | +15.8% | 12,767 | 0.0% | 0.00% | – |
| Q4 2017 | $209,000 | +14.8% | 12,767 | 0.0% | 0.00% | – |
| Q3 2017 | $182,000 | +304.4% | 12,767 | +150.3% | 0.00% | – |
| Q2 2017 | $45,000 | +73.1% | 5,100 | 0.0% | 0.00% | – |
| Q1 2017 | $26,000 | +73.3% | 5,100 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | -68.8% | 5,100 | -50.0% | 0.00% | – |
| Q3 2016 | $48,000 | +65.5% | 10,200 | +100.0% | 0.00% | – |
| Q2 2016 | $29,000 | -6.5% | 5,100 | 0.0% | 0.00% | – |
| Q1 2016 | $31,000 | -34.0% | 5,100 | 0.0% | 0.00% | – |
| Q4 2015 | $47,000 | +62.1% | 5,100 | 0.0% | 0.00% | – |
| Q3 2015 | $29,000 | -48.2% | 5,100 | 0.0% | 0.00% | – |
| Q2 2015 | $56,000 | -30.0% | 5,100 | 0.0% | 0.00% | – |
| Q1 2015 | $80,000 | +3.9% | 5,100 | 0.0% | 0.00% | – |
| Q4 2014 | $77,000 | +40.0% | 5,100 | 0.0% | 0.00% | – |
| Q3 2014 | $55,000 | -29.5% | 5,100 | 0.0% | 0.00% | – |
| Q2 2014 | $78,000 | -15.2% | 5,100 | 0.0% | 0.00% | – |
| Q1 2014 | $92,000 | +29.6% | 5,100 | 0.0% | 0.00% | – |
| Q4 2013 | $71,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |